Of the 25 included studies, when all the data were pooled in the meta-analysis, the IL-6 levels of the controls were significantly lower than those of the PCOS patients (random-effects, SMD = 0.78, 95% CI = 0.41–1.16, P<0.001; Fig 2). The gene discussed is IL6; the disease is polycystic ovary syndrome.